NeoPharm CO., LTD. (KOSDAQ: 092730)

NeoPharm CO., LTD. Revenue

NeoPharm CO., LTD. had revenue of 26.15B KRW in the quarter ending September 30, 2024, with 19.91% growth. This brings the company's revenue in the last twelve months to 112.20B, up 21.60% year-over-year. In the year 2023, NeoPharm CO., LTD. had annual revenue of 97.10B with 14.20% growth.

• Revenue (ttm): 112.20B
• Revenue Growth: +21.60%
• P/S Ratio: 1.65
• Revenue / Employee: 633.90M
• Employees: 177
• Market Cap: 180.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	97.10B	12.07B	14.20%
Dec 31, 2022	85.03B	-2.90B	-3.30%
Dec 31, 2021	87.93B	6.31B	7.72%
Dec 31, 2020	81.63B	-1.61B	-1.94%
Dec 31, 2019	83.24B	16.97B	25.60%